SCHEMBL8949893

SCHEMBL8949893

O=[PH](CP(=O)(O)O)OCNc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 3/20 0.40
CA12 O43570 1/20 0.40
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.36
MMP8 P22894 3/20 0.33
MMP14 P50281 3/20 0.33
CA14 Q9ULX7 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
FDPS P14324 2/20 0.33
MAPT P10636 2/20 0.33
CA2 P00918 1/20 0.33
MMP2 P08253 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28237020 0.75 NPSR1 (0.44) CA9CA12NPSR1TSHRALDH1A1
SCHEMBL28064849 0.75 MAPT (0.40) CA9CA12NPSR1TSHRALDH1A1
SCHEMBL8949745 0.75 TSHR (0.52) TSHRALDH1A1FDPSACP3
SCHEMBL9138295 0.73 CA9 (0.52) CA9CA12NPSR1TSHRMMP8
SCHEMBL8949914 0.71 FFAR1 (0.38) TSHRALDH1A1GAAFDPSMEN1
SCHEMBL8949644 0.68 PTPN1 (0.38) CA9CA12NPSR1TSHRALDH1A1
SCHEMBL8949897 0.67 TSHR (0.48) CA9CA12NPSR1TSHRMMP8
SCHEMBL29025199 0.66 MAPT (0.47) CA9CA12NPSR1TSHRALDH1A1
SCHEMBL7729298 0.65 FDPS (0.68) CA9CA12MMP8MMP14CA14
Phosphoric Acid SCHEMBL29169622 0.65 ALDH1A1 (0.50) CA9CA12ALDH1A1MAPTCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed
EP-0298553-A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism Norwich Eaton Pharmaceuticals, Inc. (US) 1989-01-11 EP disclosed